First‐line treatment of double‐hit and triple‐hit lymphomas: Survival and tolerance data from a retrospective multicenter French study
2020 · American Journal of Hematology · 48 citations
https://doi.org/10.1002/ajh.26068
A
Anne‐Sophie Michallet
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
192
Papers
3.0K
Citations
31
h-index
67
i10-index
Anne‐Sophie Michallet is an academic researcher from Centre Léon Bérard. The author has contributed to research in topics: Chronic Lymphocytic Leukemia Research & Lymphoma Diagnosis and Treatment & Immunodeficiency and Autoimmune Disorders. The author has an h-index of 31, co-authored 164 publications.
ORCID: 0000-0002-4256-8126Papers by this author
worksComplete remission after first-line radio-chemotherapy as predictor of survival in extranodal NK/T cell lymphoma
2012 · Journal of Hematology & Oncology · 35 citations
https://doi.org/10.1186/1756-8722-5-27
Immune checkpoint inhibitor treatment of a first cancer is associated with a decreased incidence of second primary cancer
2021 · ESMO Open · 30 citations
https://doi.org/10.1016/j.esmoop.2020.100044
A retrospective analysis of 450 TP53 mutations in a real life cohort of CLL from the French Innovative Leukemia Organization (FILO) group
2017 · HAL (Le Centre pour la Communication Scientifique Directe) · 2 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat